Nancy Cox, a CDC veteran and stalwart in global flu research, dies at 77
Nancy Cox, a pioneering figure in the field of influenza research, passed away at the age of 77 after battling glioblastoma, a form of brain cancer. For over two decades, Cox led the influenza team at the Centers for Disease Control and Prevention (CDC), transforming it from a small branch of 14 individuals into a division of more than 100 experts. She also served as the director of the World Health Organization’s Collaborating Center for the Surveillance, Epidemiology, and Control of Influenza at the CDC.
Throughout her career, Cox played a critical role in responding to seasonal flu outbreaks and preparing for potential pandemics. She was instrumental in establishing global networks for monitoring the evolution of influenza viruses and identifying novel strains with pandemic potential. Her visionary leadership and dedication to enhancing influenza surveillance systems significantly contributed to the annual updating of flu vaccines.
Colleagues and collaborators remember Cox as a highly knowledgeable and supportive leader who prioritized the professional growth of junior scientists. Her expertise in influenza virology, combined with her commitment to public health, earned her respect and admiration from peers worldwide. Cox’s efforts to integrate modern technologies into vaccine strain selection and pandemic preparedness activities have left a lasting impact on global health security.
Born and raised in rural Iowa, Cox pursued a career in virology after obtaining a doctorate from the University of Cambridge on a Marshall fellowship. She joined the CDC in 1975 and assumed leadership of the influenza branch in 1992. Cox’s work gained widespread recognition during the late 1990s and mid-2000s when the H5N1 bird flu virus emerged as a significant threat to public health.
Despite the ongoing challenges posed by H5N1 and other influenza strains, Cox remained resolute in advocating for pandemic preparedness and continuous surveillance efforts. Her contributions to the field of influenza research earned her prestigious accolades, including being named Federal Employee of the Year in 2006 and being featured on the Time Top 100 list alongside notable figures like Oprah Winfrey and Bill Gates.
In a world where influenza viruses continue to evolve and pose unpredictable threats, Nancy Cox’s legacy as a pioneering influenza researcher and public health advocate will endure. Her dedication to advancing global influenza surveillance and pandemic preparedness has left an indelible mark on the field of infectious disease research. Cox’s unwavering commitment to protecting public health serves as an inspiration to future generations of scientists working to combat infectious diseases. In the world of influenza research, there are often surprises that catch even the most seasoned scientists off guard. In 2009, the global community was faced with a pandemic caused by an H1N1 virus that had evolved in pigs, rather than the feared bird flu. This unexpected event was a challenge for experts like Cox, who often emphasized the unpredictable nature of flu seasons.
The first two confirmed cases of the H1N1 virus were found in children in California, who had no known connections to pigs or each other. As the Centers for Disease Control and Prevention (CDC) worked to understand the origins and spread of the virus, Cox, along with her team, found themselves at the forefront of the response.
During this tense period, Richard Besser, who was acting CDC director at the time, highlighted Cox’s role in providing confidence to the public through her briefings. Despite facing a personal tragedy when her house was struck by lightning and burned down, Cox remained dedicated to her work. She returned to the office the next day, focusing on the potential pandemic looming ahead.
One of Cox’s key contributions during her tenure at the CDC was her efforts to enhance global cooperation in influenza research. She worked tirelessly to build relationships with scientists from various countries, including China, and strengthen their scientific capabilities. By fostering collaborations and sharing expertise, Cox aimed to improve global influenza surveillance and response efforts.
Kanta Subbarao, who worked closely with Cox at the CDC and later at a WHO flu collaborating center in Australia, praised Cox’s diplomatic approach to international collaboration. He emphasized her belief in the importance of inviting cooperation rather than compelling it, which ultimately benefited the global fight against influenza.
Cox’s legacy lives on through her family, including her husband, daughter, stepson, and grandchildren. Her dedication to public service and commitment to advancing global health security have left a lasting impact on the field of influenza research. As we continue to navigate the ever-evolving landscape of infectious diseases, Cox’s contributions serve as a reminder of the importance of collaboration and preparedness in safeguarding public health.
